Clinical Pharmacology & TherapeuticsSCIE

文章摘录

• Assessment of the Delay in Novel Anticancer Drugs between China and the United States: A Comparative Study of Drugs Approved between 2010 and 2021 Author: Luo, Xingxian; Du, Xin; Li, Zhuangqi; Qian, Feng; Yang, Yue Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. 113, Issue 1, pp. 170-181. DOI: 10.1002/cpt.2755
• Development of Therapeutic Proteins for a New Subcutaneous Route of Administration after the Establishment of Intravenous Dosages: A Systematic Review Author: Xu, Zhenhua; Leu, Jocelyn H. H.; Xu, Yan; Nnane, Ivo; Liva, Sophia G. G.; Wang-Lin, Shun Xin; Kudgus-Lokken, Rachel; Vermeulen, An; Ouellet, Daniele Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. 113, Issue 5, pp. 1011-1029. DOI: 10.1002/cpt.2823
• Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric Patients Author: Guo, Guimu; You, Xiang; Wu, Wanhong; Chen, Jiarui; Ke, Meng; Lin, Rongfang; Huang, Pinfang; Lin, Cuihong Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cpt.2815
• The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data Author: Liu, Qi; Mathur, Raina; Xu, Yuan; Torres, Aracelis Z.; Miksad, Rebecca A.; Liu, Chao; Smithson, Haixia; Wang, Yaning; Zhu, Hao; Booth, Brian; Huang, Shiew-Mei; Zhi, Jizu; Sridhara, Rajeshwari; Blumenthal, Gideon Michael; Larkins, Erin; Mishra-Kalyani, Pallavi S.; Rivera, Donna R.; Kluetz, Paul G.; Sharon, Elad Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. 113, Issue 5, pp. 1139-1149. DOI: 10.1002/cpt.2874
• Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and Acarbose Author: Wang, Jing; Liang, Hua; Wang, You; Zheng, Xueying; Chen, Fei; Shao, Jian; Geng, Zhaoxu; Zheng, Li; Yang, Wenying; Weng, Jianping; Xu, Tao; Zhou, Kaixin Journal: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cpt.2877
• Challenges and Opportunities With Oncology Drug Development in China. Author: Bajaj G¹, Gupta M¹, Wang HH², Barrett JS³, Tan M², Rupalla K², Bertz R¹, Sheng J¹. Journal: Clin Pharmacol Ther. 2019 Feb;105(2):363-375. doi: 10.1002/cpt.1017. Epub 2018 Mar 8.
• The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label. Author: Wang YH^1,2, Chen CB^{1,2,3,4,5,6,7}, Tassaneeyakul W⁸, Saito Y⁹, Aihara M¹⁰, Choon SE¹¹, Lee HY^12,13, Chang MM¹⁴, Roa FD¹⁵, Wu CW¹⁶, Zhang J¹⁷, Nakkam N⁸, Konyoung P¹⁸, Okamoto-Uchida Y⁹, Cheung CM¹⁴, Huang JW¹⁷, Ji C¹⁷, Cheng B¹⁷, Hui RC^1,2,3, Chu CY¹⁹, Chen YJ²⁰, Wu CY²¹, Hsu CK²², Chiu TM²³, Huang YH^1,2,3, Lu CW^1,2,3,4, Yang CY^1,2,3, Lin YT^1,2,3, Chi MH^1,2,3, Ho HC^1,2,3, Lin JY^1,2,3, Yang CH^1,2,3, Chang YC^1,2,3, Su SC^1,2,5, Wang CW^1,2,5, Fan WL⁵, Hung SI²⁴, Chung WH^{1,2,3,4,5,6,7}; Asian Severe Cutaneous Adverse Reaction Consortium. Journal: Clin Pharmacol Ther. 2019 Jan;105(1):112-120. doi: 10.1002/cpt.1071. Epub 2018 Aug 9.
• S-Nitrosylation of Prostacyclin Synthase Instigates Nitrate Cross-Tolerance In Vivo. Author: Zhou SN¹, Lu JX², Wang XQ¹, Shan MR¹, Miao Z¹, Pan GP², Jian X², Li P², Ping S², Pang XY¹, Bai YP³, Liu C⁴, Wang SX^1,2,4. Journal: Clin Pharmacol Ther. 2019 Jan;105(1):201-209. doi: 10.1002/cpt.1094. Epub 2018 Aug 1.